Common dementia drug tested as new hope for tough liver cancers
NCT ID NCT06007846
Summary
This study is testing whether a drug called memantine, commonly used for Alzheimer's disease, can help control advanced liver cancer in patients who also have severe liver scarring (cirrhosis) and are too sick for standard chemotherapy. It will measure if the cancer stops growing for at least 6 months and track any changes in patients' quality of life. The goal is to find a gentler treatment option for this very sick group of patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Inova Health Care Service
NOT_YET_RECRUITINGFalls Church, Virginia, 22042, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Inova Schar Cancer Institute
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.